Reference laboratory
Scope of work and services:
- Conducting External Quality Assessment (EQA) for diagnostic laboratories engaged in the diagnosis of HIV/AIDS, viral hepatitis B and C.
- Preparation of standard serum panels and in-laboratory standards for quality control of infection diagnostics.
- Quality assessment of manufactured and imported diagnostic test systems.
- Training center for laboratory specialists from across the Republic.
Every year, laboratory specialists study under the virology course program and the professional specialization program for virologist physicians.
- Providing diagnostic services to the population using enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) methods on a self-financing basis for the diagnosis of viral hepatitis and TORCH infections.
- Scientific research activities.
- Cooperation with the World Health Organization (WHO), the Institute of the Chemistry of Plant Substances named after Academician S.Yu. Yunusov (Uzbekistan), the Central Research Institute of Epidemiology of Rospotrebnadzor (Russia), and the international organization “Doctors Without Borders”.
| № | Service Code | Service Name | Service Fee (in Sums) |
| Sample Collection | |||
| 1 | Blood Collection | 18,000 | |
| 2 | Scraping Sample Collection (for women) | 20,000 | |
| 3 | Scraping Sample Collection (for men) | 12,000 | |
| 4 | Nasopharyngeal and Oropharyngeal Swab Collection | 6,000 | |
| 5 | Sample Collection for ECLIA Testing | 13,000 | |
| 6 | Extraction for Any Infection in Mononuclear Cells (per sample) | 118,000 | |
| Laboratory Testing via ELISA | |||
| 1 | ELISA Testing for Hepatitis A (anti-HAV) | 99,000 | |
| 2 | Laboratory testing (ELISA) for Hepatitis B (HBsAg) | 91,000 | |
| 3 | Laboratory testing (ELISA) for Hepatitis C (anti-HCV) | 90,000 | |
| 4 | Laboratory testing (ELISA) for CMV IgG (TORCH infection) | 100,000 | |
| 5 | Laboratory testing (ELISA) for CMV IgM (TORCH infection) | 100,000 | |
| 6 | Laboratory testing (ELISA) for Toxoplasmosis IgG (TORCH infection) | 100,000 | |
| 7 | Laboratory testing (ELISA) for Toxoplasmosis IgM (TORCH infection) | 100,000 | |
| 8 | Laboratory testing (ELISA) for HSV IgG (TORCH infection) | 98,000 | |
| 9 | Laboratory testing (ELISA) for HSV-1/2 IgM (TORCH infection) | 98,000 | |
| 10 | Laboratory testing (ELISA) for the detection of IgG antibodies to Chlamydia and TORCH infections | 100,000 | |
| 11 | Laboratory testing (ELISA) for the detection of IgM antibodies to Chlamydia and TORCH infections | 100,000 | |
| 12 | Laboratory testing (ELISA) for the detection of IgG antibodies to Ureaplasma and TORCH infections | 104,000 | |
| 13 | Laboratory testing (ELISA) for the detection of IgG antibodies to *Mycoplasma hominis* and TORCH infections | 104,000 | |
| 14 | Laboratory testing (ELISA) for the detection of IgG antibodies to Rubella and TORCH infections | 116,000 | |
| 15 | Laboratory testing (ELISA) for the detection of IgM antibodies to Rubella and TORCH infections | 116,000 | |
| 16 | Laboratory testing (ELISA) for the detection of IgG antibodies to *Chlamydia pneumoniae* and TORCH infections | 106,000 | |
| 17 | Laboratory testing (ELISA) for HBeAg | 100,000 | |
| 18 | Laboratory testing (ELISA) for anti-HBe | 100 000 | |
| 19 | Laboratory testing (ELISA) for anti-HBsAg antibodies | 104,000 | |
| 20 | Laboratory testing (ELISA) for *Giardia* antibodies | 102,000 | |
| 21 | Laboratory testing (ELISA) for *Helicobacter* antibodies (Helicobest) | 106,000 | |
| 22 | Laboratory testing (ELISA) for Hepatitis D | 101,000 | |
| 23 | Laboratory testing (ELISA) for HBsAg (quantitative) | 106,000 | |
| 24 | Laboratory testing (ELISA) for EBV VCA-IgG/IgM: detection of antibodies to the capsid antigen (early/current infection) | 104,000 | |
| 25 | Laboratory testing (ELISA) for EBV EA-IgG: detection of antibodies to the early antigen (acute stage, reactivation) | 104,000 | |
| 26 | Laboratory testing (ELISA) for EBV NA-IgG Detection of antibodies to the nuclear antigen (past infection) | 104,000 | |
| 27 | Laboratory testing (ELISA): Measles IgM | 110,000 | |
| 28 | Laboratory testing (ELISA): Measles IgG | 116,000 | |
| 29 | Laboratory testing (ELISA): HBc IgG | 51,000 | |
| 30 | Laboratory testing (ELISA): HBc IgM | 51,000 | |
| Laboratory testing (PCR method) | |||
| 1 | Laboratory testing (PCR) for Hepatitis C RNA (qualitative) | 0 | |
| 2 | Laboratory testing (PCR) for Hepatitis B DNA (qualitative) | 0 | |
| 3 | Laboratory testing (PCR) for Hepatitis C RNA (quantitative) | 184,000 | |
| 4 | Laboratory testing (PCR) for Hepatitis B DNA (quantitative) | 173,000 | |
| 5 | Laboratory testing (PCR) for Hepatitis C RNA (genotyping) | 460,000 | |
| 6 | Laboratory testing (PCR) for Hepatitis D RNA, qualitative | 326,000 | |
| 7 | Laboratory testing (PCR) for Hepatitis D RNA, quantitative | 349,000 | |
| 8 | Laboratory testing (PCR) for HPV DNA, screening panel (12 types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59), quantitative | 189,000 | |
| 9 | Laboratory testing (PCR) for HPV DNA (types 16/18), quantitative | 474,000 | |
| 10 | Laboratory testing via PCR for HPV DNA: genotype and titer (14 types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) — genotyping + quantitative analysis | 262,000 | |
| 11 | Laboratory testing via PCR for CMV DNA | 180,000 | |
| 12 | Laboratory testing via PCR for HSV-1/2 DNA | 271,000 | |
| 13 | Laboratory testing via PCR for *Mycoplasma genitalium* DNA | 159,000 | |
| 14 | Laboratory testing via PCR for *Chlamydia trachomatis* DNA | 174,000 | |
| 15 | Laboratory testing via PCR for *Ureaplasma urealyticum/parvum* DNA | 159,000 | |
| 16 | Laboratory testing via PCR for *Toxoplasma* DNA | 160,000 | |
| 17 | Laboratory testing via Multiprime PCR for... Chlamydia / Ureaplasma / Mycoplasma | 159,000 | |
| 18 | Laboratory testing for markers of viral infections using PCR to detect RNA of Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) / "SARS-CoV-2" | 191,000 | |
| 19 | Laboratory testing for markers of viral infections using PCR to detect RNA of Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) / "SARS-CoV-2". Consumables for collection are provided | 214,000 | |
| 20 | Laboratory tests using Epstein-Brra/CMV/HSV PCR | 154,000 | |
| 21 | Laboratory tests using HBV RNA qualitative PCR | 155,000 | |
| Laboratory research express | |||
| 1 | HBsAg Kasseta Qon zardobi/plazma/qonda HBsAg ni aniqlash | 0 | |
| 2 | Anti-HCV Kasseta 3 Odam qonida HCV ga qarshi antitanalarni aniqlash | 181,000 | |
| 3 | HDV Kasseta Gepatit D virusiga qarshi antitanalarni aniqlash | 0 | |
| 4 | HAV IgM Kasseta Gepatit A virusiga qarshi IgM antitanalarni aniqlash. | 0 | |
| 5 | H. pylori Ab Kasseta Helicobacter pylori ga qarshi antitanalarni aniqlash | 64,000 | |
| 6 | H. pylori Ag Kasseta (najas) Najasda Helicobacter pylori antigenini aniqlash | 66,000 | |
| 7 | HBV 5-in-1 Kasseta HBsAg, HBsAb, HBeAg, HBeAb, HBcAb ni aniqlash | 71,000 | |
| 8 | TORCH IgM/IgG Kasseta TOXO, Qizamiq, CMV, HSV 1/2 ga qarshi IgM va IgG antitanalarni aniqlash | 69,000 | |
| 9 | HBsAb Cassette (Rapid Test Cassette) Qon (butun qon, zardob, plasma)da HBsAb – hepatit B virusiga qarshi antitanalarni aniqlash. | 62,000 | |
| Laboratory studies of liver puncture biopsy | |||
| 1 | Collection of biopsy material | 74,000 | |